B
BRIDGEBIO ONCOLOGY THERAPEUTICS, INC.
NASDAQ: BBOT (BridgeBio Oncology Therapeutics)
最近更新时间: 8小时之前3.89
-0.05 (-1.27%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | BridgeBio Oncology Therapeutics | 混合的 | 看跌 |
AIStockmoo 评分
0.5
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | 3.0 |
| 技术平均移动指标 | 1.0 |
| 技术振荡指标 | -2.5 |
| 平均 | 0.50 |
|
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Deerfield Management Company, L.P. | 30 Jun 2026 | 4,885,446 |
| Omega Fund Management, Llc | 30 Jun 2026 | 3,289,661 |
| Ecor1 Capital, Llc | 30 Jun 2026 | 2,823,126 |
| Alphabet Inc. | 30 Jun 2026 | 2,823,126 |
| Enavate Sciences Gp, Llc | 30 Jun 2026 | 2,626,946 |
| Novo Holdings A/S | 30 Jun 2026 | 2,250,000 |
| Laurion Capital Management Lp | 30 Jun 2026 | 2,002,701 |
| Armistice Capital, Llc | 30 Jun 2026 | 1,764,000 |
| Aisling Capital Management Lp | 30 Jun 2026 | 1,018,018 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合